Center-Authored Papers

Filters: Author is Alyea, Edwin P  [Clear All Filters]
Journal Article
Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Anasetti C, Dreger P, Montserrat E, Perales M-A, Alyea EP et al..  2016.  Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Copelan EA, Avalos BR, Woo Ahn K, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI et al..  2015.  Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(3):552-8. Abstract
Khera N, Emmert A, Storer BE, Sandmaier BM, Alyea EP, Lee SJ.  2014.  Costs of Allogeneic Hematopoietic Cell Transplantation Using Reduced Intensity Conditioning Regimens.. The oncologist. Abstract
Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP, Koreth J, Antin JH, Lee SJ.  2008.  Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(2):197-207. Abstract
Armand P, Gibson CJ, Cutler C, Ho VT, Koreth J, Alyea EP, Ritz J, Sorror ML, Lee SJ, Deeg HJ et al..  2012.  A disease risk index for patients undergoing allogeneic stem cell transplantation.. Blood. 120(4):905-13. Abstract
Sabloff M, Sobecks RM, Woo Ahn K, Zhu X, DeLima M, Brown JR, Inamoto Y, Holland KH, Aljurf MD, Laughlin MJ et al..  2014.  Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(3):421-4. Abstract
Martin PS, Li S, Nikiforow S, Alyea EP, Antin JH, Armand P, Cutler CS, Ho VT, Kekre N, Koreth J et al..  2016.  Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation.. Haematologica. 101(4):499-505. Abstract
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D et al..  2010.  Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(5):563-4.
Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP et al..  2017.  Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35(11):1154-1161. Abstract
Bishop MR, Alyea EP, Cairo MS, Falkenburg FJH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter DL et al..  2011.  National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(4):443-54. Abstract
Alyea EP, DeAngelo DJ, Moldrem J, Pagel JM, Przepiorka D, Sadelin M, Young JW, Giralt S, Bishop M, Riddell SR.  2010.  NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignan. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(8):1037-69. Abstract
Porter DL, Alyea EP, Antin JH, DeLima M, Estey EH, Falkenburg FJH, Hardy N, Kroeger N, Leis J, Levine J et al..  2010.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(11):1467-503. Abstract